The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy.
暂无分享,去创建一个
D. Kuban | I. Rosen | D. Followill | S. Kry | M. Salehpour | M. Stovall | R. White | I. Rosen
[1] B. Fraass,et al. Peripheral dose from megavolt beams. , 1983, Medical physics.
[2] N. Day,et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. , 1985, Journal of the National Cancer Institute.
[3] Louis K. Wagner,et al. Limitation of Exposure to Ionizing Radiation , 1994 .
[4] A. B. Brill,et al. NCRP Report No. 116, Limitation of Exposure to Ionizing Radiation National Council on Radiation Protection, Bethesda, MD, 88 pages, $22.50 , 1994 .
[5] E. Hall,et al. Photoneutrons from medical linear accelerators--radiobiological measurements and risk estimates. , 1995, International journal of radiation oncology, biology, physics.
[6] D Followill,et al. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. , 1997, International journal of radiation oncology, biology, physics.
[7] S Mutic,et al. Whole-body dose from tomotherapy delivery. , 1998, International journal of radiation oncology, biology, physics.
[8] D Verellen,et al. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] Whole-body dose from Peacock-based IMRT treatment , 2000 .
[10] D. Brenner,et al. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery , 2000, Cancer.
[11] E. Ron. Ionizing radiation and cancer risk: evidence from epidemiology , 2002, Pediatric Radiology.
[12] J. Buatti,et al. In vivo determination of extra-target doses received from serial tomotherapy. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] E. Hall,et al. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.
[14] A. D'Amico,et al. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Omar Chibani,et al. Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs. , 2003, Medical physics.
[16] David S Followill,et al. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. , 2005, International journal of radiation oncology, biology, physics.